I’ve seen several such patients who have no secondary causes for bone loss, on adequate calcium/vitamin D, and compliant with denosumab who do not show improvement in BMD despite several doses. Although neutralizing antibodies to denosumab were not detected in the clinical trials, I am curious to know if this is something that people suspect or if there are other causes for treatment failure.